2023
DOI: 10.1016/j.prp.2023.154457
|View full text |Cite
|
Sign up to set email alerts
|

miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 48 publications
(4 citation statements)
references
References 252 publications
0
4
0
Order By: Relevance
“…LncRNAs are arranged in secondary and three-dimensional structures so they can function as RNA and or protein [5]. The identification of non-coding RNA, such as long non-coding RNA (lncRNA) and microRNA (miRNA), in the advancement of human diseases has broadened to encompass potential connections with various conditions [6][7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…LncRNAs are arranged in secondary and three-dimensional structures so they can function as RNA and or protein [5]. The identification of non-coding RNA, such as long non-coding RNA (lncRNA) and microRNA (miRNA), in the advancement of human diseases has broadened to encompass potential connections with various conditions [6][7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%
“…The basic goal of TE is to repair damaged tissues and replace them with new biological ones ( Gaspar et al, 2020 ; Lavrador et al, 2021 ; El-Husseiny et al, 2022c ; El-Husseiny et al, 2022d ; El-Husseiny et al, 2022f ; Sharun et al, 2023 ). Cell biology and biochemistry are required for this interdisciplinary process ( El-Husseiny et al, 2022d ; Doghish et al, 2023 ; El-Mahdy et al, 2023 ; Mady et al, 2023 ; Sharun et al, 2023 ). For clinical applications, clinical medical and material sciences investigations are also included ( Gaspar et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…The current scarcity of human organs and tissues appropriate for life-saving transplants is expected to persist in the future despite the great endeavors to close the donation gap [ 1 , 2 , 3 , 4 , 5 , 6 ]. Hence, it is highly crucial to introduce efficient alternatives to avoid the high incidence of deaths among patients that occur due to the long waiting lists for donor organs/tissues or due to receiving suboptimal treatments [ 7 , 8 , 9 , 10 , 11 ]. Animal-originated organs/tissues (xenotransplants) have been recently introduced as efficient and potential alternatives to solve this problem.…”
Section: Introductionmentioning
confidence: 99%